• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

German Merck finally gets yes for MS drug Mavenclad

cafead

Administrator
Staff member
  • cafead   Apr 02, 2019 at 04:42: PM
via The FDA approved the drug under a comparatively restrictive label, however, likely meaning the market opportunity for German Merck is small.

article source